Medtronic's stent graft shows promising results in first-in-man trial

11/21/2013 | MassDevice.com (Boston)

Medtronic said its Valiant Mona LSA stent graft showed positive results in a study evaluating use of the device in treating aortic aneurysms of the left subclavian artery. The first-in-man study, which is part of the FDA's Innovation Pathway, indicated 100% technical success in device placement and 100% patency in both the branch and main grafts, with no reports of leaks.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX